• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周动脉疾病患者纤维蛋白凝块特性改变。

Altered fibrin clot properties in patients with premature peripheral artery disease.

作者信息

Okraska-Bylica Agnieszka, Wilkosz Tadeusz, Słowik Lidia, Bazanek Marta, Konieczyńska Małgorzata, Undas Anetta

机构信息

Department of Diagnostics, John Paul II Hospital, Kraków, Poland.

出版信息

Pol Arch Med Wewn. 2012;122(12):608-15. doi: 10.20452/pamw.1535. Epub 2012 Dec 11.

DOI:10.20452/pamw.1535
PMID:23235487
Abstract

INTRODUCTION

It has been shown that formation of denser and poorly lysable fibrin clots is observed in elderly patients with peripheral artery disease (PAD).

OBJECTIVES

The aim of the study was to test the hypothesis that premature PAD is associated with more prothrombotic fibrin clot phenotype.

PATIENTS AND METHODS

Ex‑vivo plasma fibrin clot permeability, turbidity, and susceptibility to lysis were evaluated in 31 premature PAD patients (median ankle brachial index [ABI], 0.75; interquartile range, 0.5-0.8) aged 55 or less and 32 PAD patients (ABI, 0.66; 0.56-0.76) aged over 55 years. Subjects without PAD matched for age and sex (n = 40) served as controls.

RESULTS

Premature PAD patients were characterized by 32% lower clot permeability (Ks) (P <0.001), 7% longer clot lysis time (t50%) (P = 0.004), and 31% higher maximum D-dimer levels released from fibrin clots (D-Dmax) (P <0.001) compared with controls. These differences remained significant after adjustment for risk factors and medications. None of the fibrin clot parameters differed between premature and older PAD patients. There were correlations between fibrin clot parameters and CRP in premature PAD patients and with ABI in older PAD patients. In a multiple regression model, premature PAD and ABI were independent predictors of Ks, and premature PAD and plasma fibrinogen of the maximum absorbance of a fibrin gel.

CONCLUSIONS

Plasma fibrin clots show similarly abnormal prothrombotic phenotype in premature and older PAD patients. However, different factors influence fibrin clot parameters in these patient groups. Premature PAD was an independent predictor of clot permeability and maximum absorbance of a fibrin gel.

摘要

引言

研究表明,外周动脉疾病(PAD)老年患者会形成更致密且难溶解的纤维蛋白凝块。

目的

本研究旨在验证过早发生PAD与更易形成血栓的纤维蛋白凝块表型相关这一假说。

患者与方法

对31名年龄55岁及以下的过早发生PAD患者(中位踝臂指数[ABI]为0.75;四分位间距为0.5 - 0.8)、32名年龄超过55岁的PAD患者(ABI为0.66;0.56 - 0.76)以及40名年龄和性别匹配的无PAD受试者作为对照,评估其体外血浆纤维蛋白凝块的通透性、浊度和溶解敏感性。

结果

与对照组相比,过早发生PAD的患者凝块通透性(Ks)降低32%(P <0.001),凝块溶解时间(t50%)延长7%(P = 0.004),纤维蛋白凝块释放的最大D - 二聚体水平(D - Dmax)升高31%(P <0.001)。在对危险因素和药物进行调整后,这些差异仍然显著。过早发生PAD的患者与老年PAD患者之间的纤维蛋白凝块参数无差异。过早发生PAD的患者中,纤维蛋白凝块参数与CRP相关,老年PAD患者中则与ABI相关。在多元回归模型中,过早发生PAD和ABI是Ks的独立预测因素,过早发生PAD和血浆纤维蛋白原是纤维蛋白凝胶最大吸光度的独立预测因素。

结论

过早发生PAD的患者和老年PAD患者的血浆纤维蛋白凝块均表现出类似的异常促血栓形成表型。然而,不同因素影响这些患者群体的纤维蛋白凝块参数。过早发生PAD是凝块通透性和纤维蛋白凝胶最大吸光度的独立预测因素。

相似文献

1
Altered fibrin clot properties in patients with premature peripheral artery disease.外周动脉疾病患者纤维蛋白凝块特性改变。
Pol Arch Med Wewn. 2012;122(12):608-15. doi: 10.20452/pamw.1535. Epub 2012 Dec 11.
2
Abnormal plasma fibrin clot characteristics are associated with worse clinical outcome in patients with peripheral arterial disease and thromboangiitis obliterans.异常的血浆纤维蛋白凝块特征与外周动脉疾病和血栓闭塞性脉管炎患者的临床预后不良有关。
Atherosclerosis. 2011 Apr;215(2):481-6. doi: 10.1016/j.atherosclerosis.2010.12.040. Epub 2011 Jan 19.
3
Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation.消化道癌症患者血浆纤维蛋白凝块特性的改变:与凝血酶生成增加的关系。
Thromb Res. 2013 Mar;131(3):262-7. doi: 10.1016/j.thromres.2012.11.033. Epub 2012 Dec 27.
4
Reduced plasma fibrin clot permeability and susceptibility to lysis in patients with inflammatory bowel disease: a novel prothrombotic mechanism.炎症性肠病患者血浆纤维蛋白凝块通透性降低和对溶解的敏感性:一种新的促血栓形成机制。
Inflamm Bowel Dis. 2013 Nov;19(12):2616-24. doi: 10.1097/01.MIB.0000437041.59208.44.
5
Altered fibrin clot structure/function in patients with antiphospholipid syndrome: association with thrombotic manifestation.抗磷脂综合征患者纤维蛋白凝块结构/功能改变:与血栓表现相关。
Thromb Haemost. 2014 Aug;112(2):287-96. doi: 10.1160/TH13-11-0980. Epub 2014 Mar 20.
6
Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.多发性骨髓瘤患者的血浆纤维蛋白凝块性质和纤维蛋白溶解改变。
Eur J Clin Invest. 2014 Jun;44(6):557-66. doi: 10.1111/eci.12269.
7
Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.血浆凝块通透性增加及对溶解的易感性与不明原因的月经过多相关:一项病例对照研究。
PLoS One. 2015 Apr 24;10(4):e0125069. doi: 10.1371/journal.pone.0125069. eCollection 2015.
8
Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.患有活动期类风湿关节炎患者的纤维蛋白凝块性质发生不利改变。
Thromb Res. 2010 Jul;126(1):e11-6. doi: 10.1016/j.thromres.2010.04.007. Epub 2010 May 14.
9
Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.嗜酸性肉芽肿性多血管炎(Churg-Strauss综合征)患者纤维蛋白凝块特性的不良改变:与凝血酶生成和嗜酸性粒细胞增多的关联
PLoS One. 2015 Nov 5;10(11):e0142167. doi: 10.1371/journal.pone.0142167. eCollection 2015.
10
Altered plasma fibrin clot properties are associated with in-stent thrombosis.血浆纤维蛋白凝块特性的改变与支架内血栓形成有关。
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):276-82. doi: 10.1161/ATVBAHA.109.194936. Epub 2009 Nov 12.

引用本文的文献

1
Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice.心血管疾病中的纤维蛋白凝块特性:从基础机制到临床实践。
Cardiovasc Res. 2023 Mar 17;119(1):94-111. doi: 10.1093/cvr/cvad017.
2
Relationship between serum homocysteine, fibrinogen, lipoprotein-a level, and peripheral arterial disease: a dose-response meta-analysis.血清同型半胱氨酸、纤维蛋白原、脂蛋白(a)水平与外周动脉疾病的关系:剂量反应荟萃分析。
Eur J Med Res. 2022 Nov 21;27(1):261. doi: 10.1186/s40001-022-00870-1.
3
Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes.
动脉粥样硬化性血管疾病中的纤维蛋白凝块特性:从病理生理学到临床结果
J Clin Med. 2021 Jul 5;10(13):2999. doi: 10.3390/jcm10132999.
4
Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long-term follow-up study.2型糖尿病患者血浆纤维蛋白凝块特性与心血管死亡率:一项长期随访研究
Cardiovasc Diabetol. 2021 Feb 18;20(1):47. doi: 10.1186/s12933-021-01230-9.
5
Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death.癌症患者静脉血栓栓塞、动脉血栓形成和死亡风险的血浆凝块形成和溶解的体外特性。
Transl Res. 2020 Jan;215:41-56. doi: 10.1016/j.trsl.2019.08.009. Epub 2019 Aug 29.
6
Thrombin-generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause.在不明原因出血的患者中,凝血酶生成能力、血浆血栓形成和血栓溶解受到损害。
J Thromb Haemost. 2019 Sep;17(9):1478-1488. doi: 10.1111/jth.14529. Epub 2019 Jul 15.
7
Restenosis is associated with prothrombotic plasma fibrin clot characteristics in endovascularly treated patients with critical limb ischemia.血管内治疗的严重肢体缺血患者中,再狭窄与促血栓形成的血浆纤维蛋白凝块特征相关。
J Thromb Thrombolysis. 2019 May;47(4):540-549. doi: 10.1007/s11239-019-01826-9.
8
Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.血浆凝块通透性增加及对溶解的易感性与不明原因的月经过多相关:一项病例对照研究。
PLoS One. 2015 Apr 24;10(4):e0125069. doi: 10.1371/journal.pone.0125069. eCollection 2015.